Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children
- PMID: 22008654
- DOI: 10.1097/QAD.0b013e32834dc5fc
Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children
Abstract
Background: Dyslipidemia is observed among older children and adults with HIV. We examined nonfasting cholesterol and triglycerides in two groups of 12-23-month-old Latin American children - HIV-infected vs. HIV-exposed but uninfected (HEU).
Methods: HIV-infected and HEU children in Latin America and Jamaica were enrolled in an observational cohort. Eligibility for this analysis required having cholesterol and triglyceride results available during the second year of life.
Results: HIV-infected (n = 83) children were slightly older at the time of lipid testing than the HEU (n = 681). Forty percent of the HIV-infected children were on protease inhibitor-based antiretroviral therapy (ART); 41% were not on ART. There was no statistically significant difference in mean cholesterol concentrations (mg/dl) by HIV status; however, the HIV-infected children had higher mean triglyceride concentrations. The prevalence of high cholesterol (>200 mg/dl) and high triglycerides (>110 mg/dl) was higher among the HIV-infected vs. HEU. Among the HIV-infected children, mean cholesterol and triglyceride concentrations varied by ART. Children receiving no ART had a significantly lower mean cholesterol concentration. Those receiving protease inhibitor-containing ART had a significantly higher mean triglyceride concentration compared to the other two antiretroviral regimen groups.
Conclusion: A greater proportion of HIV-infected children at 12-23 months have hyperlipidemia when compared to HEU children, with the highest triglyceride concentrations observed among those receiving protease inhibitor-containing ART, and the lowest cholesterol levels among those not receiving ART. Implications of these findings will require continued follow-up of HIV-infected children who initiate therapy early in life.
Similar articles
-
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.BMC Infect Dis. 2005 Jan 12;5:2. doi: 10.1186/1471-2334-5-2. BMC Infect Dis. 2005. PMID: 15647105 Free PMC article. Clinical Trial.
-
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.J Microbiol Immunol Infect. 2011 Aug;44(4):258-64. doi: 10.1016/j.jmii.2010.08.003. Epub 2011 Jan 20. J Microbiol Immunol Infect. 2011. PMID: 21524961 Clinical Trial.
-
Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.Pediatrics. 2002 Nov;110(5):e56. doi: 10.1542/peds.110.5.e56. Pediatrics. 2002. PMID: 12415062
-
Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.J Infect. 2001 Apr;42(3):181-8. doi: 10.1053/jinf.2001.0829. J Infect. 2001. PMID: 11545549 Review.
-
Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment.Scand J Infect Dis. 2000;32(2):111-23. doi: 10.1080/003655400750045196. Scand J Infect Dis. 2000. PMID: 10826894 Review.
Cited by
-
Dyslipidemia in HIV-Infected Children and Adolescents on Antiretroviral Therapy Receiving Care at Kilimanjaro Christian Medical Centre in Tanzania: A Cross-Sectional Study.Infect Dis (Auckl). 2020 Aug 26;13:1178633720948860. doi: 10.1177/1178633720948860. eCollection 2020. Infect Dis (Auckl). 2020. PMID: 32922028 Free PMC article.
-
Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.HIV Med. 2018 Mar;19(3):175-183. doi: 10.1111/hiv.12566. Epub 2017 Nov 21. HIV Med. 2018. PMID: 29159965 Free PMC article.
-
Serum lipid and glucose profiles in HIV-positive Nigerian children.J Virus Erad. 2017 Jul 1;3(3):157-162. J Virus Erad. 2017. PMID: 28758024 Free PMC article.
-
Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.Indian J Pediatr. 2016 Mar;83(3):226-31. doi: 10.1007/s12098-015-1859-3. Epub 2015 Sep 3. Indian J Pediatr. 2016. PMID: 26334860
-
Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age.Pediatr Infect Dis J. 2013 Jul;32(7):e298-304. doi: 10.1097/INF.0b013e31828afb2a. Pediatr Infect Dis J. 2013. PMID: 23385950 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical